Scinai Immunotherapeutics Ltd. (SCNI): Wutah pendapatan triwulanan

Simbol resmi perusahaan Scinai Immunotherapeutics (SCNI)

High debt leverage and reliance on CDMOs during the advancement of dermatitis therapy create risks, where the 565.80 mark on the general GURU.Markets platform chart serves as a key metric for quarterly revenue growth rates for Scinai Immunotherapeutics (SCNI). Stability is maintained through in-house GMP production while outsourcing clinical trials, although a fierce scientific race for government grants against global behemoths complicates scaling.

SCNI (Scinai) riwayat Tingkat wutah dodolan sajrone kuartal saka 21.02.2024 nganti 21.11.2026

Ringkesan rincian data analitis Scinai Immunotherapeutics Ltd. (SCNI)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis fundamental perusahaan:Scinai Immunotherapeutics - SCNI
Produk sing diprodhuksi scinai.com

Scinai Immunotherapeutics (SCNI) aims to scale its biologics, yet high costs associated with pilot lines are limiting operational efficiency. The quarterly revenue growth history on GURU.Markets measures the dynamics of fund inflows relative to the previous quarter, allowing investors to assess the real pace of demand recovery and the overcoming of volume stagnation, which is critical for confirming the company's long-term exit from its restructuring phase.

Perusahaan pesaing

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Wutah pendapatan kuartal marang kuartal|Aerovate Therapeutics Inc (JBIO) - Wutah pendapatan triwulanan|ACRS (Aclaris Therapeutics, Inc) - Wutah pendapatan triwulanan|Kyverna (KYTX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan TLSA|Wutah dodolan triwulanan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Wutah dodolan triwulanan|THTX: Wutah dodolan kuartal marang kuartal|AVTX - Wutah pendapatan kuartal marang kuartal|ELDN: Wutah pendapatan kuartal marang kuartal|Agenus Inc. (AGEN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Climb Bio Inc|ZURA (Zura Bio Ltd) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan aTyr Pharma Inc|Wutah pendapatan triwulanan ADAG|Tingkat wutah dodolan sajrone kuartal ImageneBio|Wutah pendapatan triwulanan STTK (Shattuck Labs Inc)|Wutah pendapatan triwulanan Equillium, Inc. EQ|CNTB - Wutah pendapatan kuartal marang kuartal|Immunic Therapeutics (IMUX) - Wutah dodolan triwulanan|ATRA: Wutah pendapatan triwulanan|InflaRx GmbH (IFRX) - Wutah pendapatan triwulanan|XFOR (x4pharma.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Adicet Bio|Wutah pendapatan kuartal marang kuartal Celularity Inc (CELU)|Wutah dodolan triwulanan INmune Bio Corp INMB|Wutah pendapatan kuartal marang kuartal Barinthus Biotherapeutics plc BRNS|KZR - Wutah dodolan triwulanan|sabbiotherapeutics.com - Wutah pendapatan triwulanan|akaritx.com (AKTX) - Wutah dodolan triwulanan|ENLV: Wutah pendapatan triwulanan|QTTB (Q32 Bio Inc) - Wutah pendapatan kuartal marang kuartal|GOVX (geovax.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Edesa Biotech Corp|Wutah pendapatan triwulanan IBIO|Wutah dodolan triwulanan Carisma Tx CARM|Wutah pendapatan kuartal marang kuartal XTL Biopharmaceuticals Ltd XTLB|Wutah pendapatan triwulanan Bolt Biotherapeutics BOLT|HCW Biologics - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Wutah dodolan triwulanan|Aditxt Corp - Tambahing pendapatan triwulanan|GRI (GRI Bio Inc) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan XORTX Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Vyome Therapeutics (HIND)|REVB - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Indaptus Therapeutics, Inc. INDP|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan